欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2244/001
药品名称
Gemcit
活性成分
gemcitabine hydrochloride 38.0 mg/ml
剂型
Powder for solution for infusion
上市许可持有人
Fresenius Kabi Pharma Portugal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 08828/0219 - 0026
Germany (DE)
Norway (NO)
Lithuania (LT)
Gemcit 38mg/ml milteliai infuziniam tirpalui
Romania (RO)
Gemcirena 38 mg/ml, pulbere pentru soluţie perfuzabilă
许可日期
2009/01/07
最近更新日期
2024/08/13
药物ATC编码
L01BC05 gemcitabine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
PIL_Clean_Common_English
Date of last change:2024/09/06
Final SPC
|
SPC_Clean_Common_English_1_
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase